Leading Active Pharmaceutical Ingredient Manufacturer Advances Global Pharmaceutical Through Integrated Capabilities

In the global pharmaceutical manufacturing landscape, HK Neopharm Limited has been increasingly recognized by industry observers as a noteworthy participant in the active pharmaceutical ingredient ...
Business Matters

Leading CDMO Companies in India: Key Players & Industry Outlook (2026)

Over the last decade, India has emerged as a significant hub for pharmaceutical outsourcing. The country has moved beyond its traditional role as a generics manufacturing center to develop a diverse ...
Fierce Pharma

Teva to lay off 250 at API unit as search for new owner drags on: report

Teva Pharmaceuticals plans to remove 250 jobs at its CDMO unit over the next two years, Israeli business news outlet Globes ...

Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology

VANCOUVER, BC / ACCESS Newswire / June 9, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce the initiation of ...

Onco-Innovations Limited: Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology

VANCOUVER, BC / ACCESS Newswire / June 9, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce the initiation of pro ...
Regulatory Affairs Professionals Society

Pharma groups say SUPAC guidelines should be updated, better aligned with ICH

Three major pharmaceutical industry groups—two in the US and one in India—have called for changes to the US Food and Drug ...

Can Supriya Life Sciences unlock its next leg of growth beyond APIs?

Over the last few years, Supriya Life Sciences has expanded beyond its traditional API business. By targeting markets ...

Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program

VANCOUVER, BC / ACCESS Newswire / June 5, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered ...

Persist AI Teams up with Microsize and Micromacinazione (Micmac) to Launch First-of-Its-Kind Early-Stage "Micromill" Formulation Platform, Enabling Drug Development Decision ...

Persist AI, an AI and robotics-powered pharmaceutical formulation research company, today announced a strategic collaboration with Microsize and Micromacinazione, pioneers in pharmaceutical ...
Pharm Exec

GLP-1 Patent Expiry & the Rise of Generics: Transforming the Drug Delivery Device Landscape & Procurement Strategy

Patent expiry across API, formulation, and device IP is expected to catalyze biosimilar competition, expanding access while compressing pricing across pharmaceutical and device value chains.
PharmTech

AI and Predictive Modeling in Small Molecule Formulation and Process Development

This conversation will explore the real-world impact of AI in small molecule formulation and process development, separating tangible progress from industry hype. The discussion will focus on where AI ...